Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-07

FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron under an ANDA held by PAI Holdings dba PAI Pharma, indicating a supplemental regulatory action for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)